Can Red Light Therapy Actually Heal Gum Inflammation?

Red light therapy has become a fixture of the wellness world. It is marketed for skin, recovery, inflammation, hair growth, and increasingly for oral health, sometimes with the promise of healthier gums from light exposure alone.

That can sound suspiciously easy. But unlike many wellness claims, there is genuine human clinical research behind the idea.

In a randomized split-mouth trial, researchers studied 13 patients whose fixed orthodontic appliances had just been removed. All received professional tooth cleaning. One upper quadrant then received photobiomodulation using a 660 nm visible red laser, while the opposite quadrant received a sham application with the laser switched off. Four to six days later, inflammation had improved on both sides, but bleeding measurements were significantly lower on the light-treated side [1].

That is a real clinical result. It is also a long way from proving that red light can cure gum disease.

The more useful question is not whether red light works. It is what kind of light was used, at what dose, for which condition, and whether the light adds anything after the cause of the inflammation has been addressed.

What does healing inflamed gums actually mean?

The word healing can hide several different biological claims.

Gums bleeding less after treatment is one outcome. Reducing an inflammation score is another. Restoring periodontal attachment or bone already destroyed by periodontitis is a much larger claim.

The available trials do not justify treating those outcomes as interchangeable.

A 2025 randomized study illustrates the distinction. Twenty patients with cancer undergoing chemotherapy took part in a split-mouth trial in which each patient received scaling and root planing in one quadrant, and the same treatment plus five sessions of photobiomodulation in another. The light was delivered by a 635 nm diode laser at 50 mW with an energy density of 2 J per square centimetre, in continuous mode, applied to the gingiva on both the cheek and tongue sides [2].

Both sides improved from baseline on gingival and plaque indices, and the photobiomodulation side did better than the control side on those measures. Clinical attachment level was measured too, and the reported benefit was in the inflammation and plaque indices rather than in attachment [2].

So a finding that gums look or bleed less inflamed should not be translated into a claim that red light regenerated lost periodontal support.

There is emerging research in periodontal regeneration, but it also needs careful reading. A 2025 randomized trial studied 30 intrabony periodontal defects, comparing a bone graft alone against the same graft plus photobiomodulation at 810 nm, or plus dual-wavelength photobiomodulation at 810 and 650 nm. The dual-wavelength group showed better results on several clinical and radiographic measures, including a mean 0.82 mm greater linear bone fill and a mean 0.50 mm greater reduction in defect depth [7].

But the light was being added to bone-graft regenerative surgery. The study does not show that shining red light on untreated periodontal bone loss regrows the bone by itself. That distinction should stay in view throughout the whole red-light conversation.

What photobiomodulation is supposed to do

The relevant form of light treatment is called photobiomodulation, or PBM.

PBM uses relatively low-intensity visible or near-infrared light under defined exposure conditions to influence biological activity without intentionally cutting or thermally destroying tissue.

The biological idea is plausible.

In 2024, Tanum and colleagues studied human gingival cells in a laboratory model. The cells were pre-irradiated with red or near-infrared LED light before being challenged with intact, living oral microbes rather than isolated bacterial fragments [4].

The light-pretreated cells showed changes in viability, proliferation, handling of reactive oxygen species, inflammatory activity, and production of antimicrobial peptides.

The most interesting result came from a control condition. When the microbes were exposed to the light without the gingival cells present, direct light exposure did not significantly affect microbial viability under those experimental conditions. Yet fewer microorganisms were recovered when light-pretreated gingival cells were present [4].

The researchers interpreted this as evidence that the light enhanced the antimicrobial response of the host cells rather than acting as a disinfectant.

That supports a more sophisticated hypothesis than the idea that red light kills gum-disease bacteria. Photobiomodulation may change how gingival cells respond to microbial challenge.

The limitation is enormous. This was cultured cells in a dish, pretreated with light before a controlled microbial challenge. It was not a clinical treatment of anyone with gingivitis or periodontitis. The authors stated that different light parameters could change the response and that further studies were needed to determine clinical efficacy [4].

The study also disclosed relevant commercial interests. Two of the authors are co-founders of a company working in this area, and four are named inventors on a United States patent application. The work received National Institutes of Health and National Science Foundation funding [4].

It establishes biological plausibility, not a prescription for home treatment.

The visible-red trial that showed an effect

The 2018 Stein trial remains one of the clearest human studies relevant to this question, because it actually used visible red light and examined gingival inflammation.

Thirteen patients with gingivitis associated with fixed orthodontic appliances were studied immediately after the appliances were removed and their teeth professionally cleaned. Each patient acted as their own control [1].

One upper quadrant received 660 nm photobiomodulation at 100 mW, a power density of 100 mW per square centimetre, and an energy density of 2 J per square centimetre at each application point. The opposite quadrant received a sham application with the laser switched off. The investigator taking the measurements did not know which quadrant had been treated [1].

Four to six days later, the papilla bleeding index and bleeding on probing had fallen on both sides. Both measurements were significantly lower on the treated side [1].

The result is promising, but narrow. The participants were young, with a mean age of about 16 years. There were only 13 of them. Their gingivitis had developed in the specific context of fixed orthodontic treatment. The brackets had been removed and professional cleaning had already happened before the laser was applied.

The defensible conclusion is that under that specific 660 nm protocol, adjunctive photobiomodulation accelerated short-term improvement in bleeding measures after professional cleaning, in a small group of adolescents with orthodontic-appliance-associated gingivitis.

That does not establish that 660 nm red light alone treats ordinary gingivitis.

Periodontitis gives a less consistent answer

The evidence becomes considerably messier when researchers study established periodontitis.

In a 2025 randomized split-mouth trial, Dervisbegovic and colleagues enrolled 30 patients with moderate to severe periodontitis. Three were excluded after starting antibiotics and seven were lost to follow-up, leaving 20 patients in the final analysis, covering roughly 1,700 sites per group [3].

Both sides of each mouth received scaling and root planing. During the two final debridement sessions, one side additionally received low-level laser therapy with a 980 nm near-infrared diode laser, applied for 60 seconds at half a millimetre from the gingiva, at a maximum energy density of 21.7 J per square centimetre. The other side received a sham procedure with the laser inactive [3].

Twelve weeks later, bleeding, probing depth, and clinical attachment had improved substantially on both sides. But the investigators found no statistically significant difference between the laser side and the control side for any clinical parameter. Reductions in Porphyromonas gingivalis and Treponema denticola were slightly greater on the laser side, but not significantly so [3].

The authors concluded that low-level laser therapy with the chosen settings did not provide a benefit during initial nonsurgical periodontal treatment, and noted that no unified clinical protocol for this treatment currently exists [3].

A 2026 randomized trial adds another layer. Twenty-seven patients received three different treatments at different periodontal sites, across 81 quadrants and 596 sites: scaling and root planing alone, the same plus low-intensity diode laser therapy, and the same plus high-intensity diode laser therapy [5].

All groups improved. The clearer additional effect occurred in the high-intensity group rather than the low-intensity group [5].

That distinction matters, because high-intensity laser treatment is not simply a stronger version of consumer red-light therapy. High-intensity applications are used for effects such as decontamination and tissue removal, while low-intensity applications are intended for photobiomodulation.

The study also has real limits: 27 patients, a short follow-up, and site-level randomization within patients, which creates statistical complications. So it does not overturn the broader picture.

Different optical treatments produce different results, and a positive study of a high-intensity dental laser is not evidence that ordinary red-light photobiomodulation will do the same thing.

The light may change the response without removing the trigger

One pattern runs through nearly all of the clinically relevant trials.

The light is being used alongside conventional dental treatment.

In the gingivitis trial, the brackets were removed and the teeth professionally cleaned before any light was applied [1]. In the chemotherapy trial, patients received scaling and root planing alongside the light [2]. In the periodontitis split-mouth trial, both sides received nonsurgical treatment, and the question was whether adding light produced anything further [3]. In the regeneration trial, the light was added to bone-graft surgery [7].

The laboratory evidence fits the same picture. Light altered how gingival cells responded to microbial challenge, but direct exposure did not kill the tested microorganisms [4].

A useful distinction is therefore:

Plaque control addresses a major inflammatory stimulus.

Photobiomodulation may modify the tissue response to that stimulus and the healing environment afterward.

Those are different therapeutic jobs, and only one of them removes the cause.

What about light-based devices used at home?

This part of the evidence has changed, and the honest position has changed with it.

It is no longer accurate to say that light-based home oral devices have never been tested in meaningful randomized trials.

In 2026, the Journal of Periodontology published the HOPE-CP randomized trial, involving 200 adults with stage I to III periodontitis receiving supportive periodontal care. Half were assigned to add daily use of a home light-based device to their routine. At six months, the group using the device had lower bleeding on probing, less visible plaque, and fewer periodontal sites with deep probing depths than the group receiving supportive care alone [6].

But this was not a trial of generic red-light photobiomodulation.

The system studied combines two wavelengths, one in the blue range and one in the near-infrared range, together with a photosensitising mouth rinse. The near-infrared light activates that external photosensitiser, while the blue light contributes an antibacterial effect. The treatment is therefore described as dual-light antibacterial photodynamic therapy, with photobiomodulation considered a possible additional effect of the near-infrared component rather than the main mechanism [6].

Because the treatment combines two wavelengths with a photosensitiser, the trial cannot show how much of the clinical benefit, if any, came specifically from photobiomodulation.

There is also relevant financial context. The study disclosed funding from the company behind the system, and two of the authors disclosed ownership interests in it [6]. That does not invalidate a randomized trial, but it belongs in view when reading results about a commercial product.

The study nevertheless changes the discussion. The accurate statement is now narrower than a blanket dismissal and narrower than a blanket endorsement.

There is randomized evidence for one specific home dual-light photodynamic system used as an adjunct to professional periodontal care. That evidence cannot be transferred to ordinary red-light mouthpieces using different wavelengths, different doses, different mechanisms, and no photosensitiser.

Why wavelength alone tells you very little

Consider how different these studies actually are.

The gingivitis trial used 660 nm visible red light at a defined power and dose, applied at specified points [1]. The chemotherapy trial used 635 nm at 50 mW and 2 J per square centimetre across five sessions [2]. The periodontitis split-mouth trial used 980 nm near-infrared light at up to 21.7 J per square centimetre [3]. The regeneration trial used 810 nm alone or 810 combined with 650 nm, alongside bone grafting [7]. The home trial used a blue and near-infrared combination with a photosensitising rinse [6].

These are not interchangeable treatments.

Wavelength matters, but so do irradiance, total energy delivered, exposure duration, distance from the tissue, treatment frequency, beam geometry, how deep the target tissue sits, and whether the intended mechanism is photobiomodulation, photodynamic antibacterial action, thermal laser activity, or some combination.

That leads to a useful rule.

Red describes part of the light spectrum. It does not describe a complete treatment protocol.

A product advertising 660 nm light cannot claim equivalence to the Stein trial merely because the wavelength matches. The delivered biological dose has to match closely enough for the comparison to mean anything, and ideally the specific approach needs its own clinical testing.

So can red light therapy actually heal gum inflammation?

The evidence supports a qualified yes for inflammation, but not a broad claim that red light heals gum disease.

Precisely delivered visible-red photobiomodulation has reduced short-term gingival inflammatory measures in small randomized human trials, always as an addition to professional care [1] [2]. Laboratory evidence shows that red and near-infrared light can alter how gingival cells respond to microbial challenge [4].

But another randomized trial found no additional periodontal benefit at all from low-intensity near-infrared photobiomodulation beyond conventional therapy under the protocol tested [3]. And newer research reinforces a central point: high-intensity dental lasers, low-intensity photobiomodulation, antimicrobial photodynamic therapy, and consumer red-light devices should not be treated as though they were the same intervention [5] [6].

So the most accurate answer is narrow. Specific photobiomodulation protocols may accelerate short-term improvement in some measures of gingival inflammation when used as an adjunct to appropriate dental care. The evidence does not establish generic red-light therapy as a stand-alone treatment for gingivitis or periodontitis.

And although some regenerative studies report better clinical or radiographic outcomes when photobiomodulation is combined with periodontal regenerative surgery, that is not evidence that a home red-light device can regrow periodontal attachment or bone by itself [7].

Persistent bleeding, swelling, gum recession, deepening pockets, or loose teeth are reasons to be examined, not reasons to buy a light.

The science here is real. The universal claim that red light heals your gums is not.

Primary sources

1. Stein S, Schauseil M, Hellak A, Korbmacher-Steiner H, Braun A. Influence of Photobiomodulation Therapy on Gingivitis Induced by Multi-Bracket Appliances: A Split-Mouth Randomized Controlled Trial. Photomedicine and Laser Surgery. 2018;36(8):399-405. DOI 10.1089/pho.2017.4404.
2. Firoozi P, Ghaznavi D, Fekrazad R. The Effect of Photobiomodulation on Periodontal Clinical Status of Patients with Cancer During Chemotherapy: A Randomized Clinical Trial. Photobiomodulation, Photomedicine, and Laser Surgery. 2025. Split-mouth trial in 20 patients with cancer.
3. Dervisbegovic S, Lettner S, Tur D, Laky M, Georgopoulos A, Moritz A, Sculean A, Rausch-Fan X. Adjunctive low-level laser therapy in periodontal treatment: A randomized clinical split-mouth trial. Clinical Oral Investigations. 2025;29(5):273. DOI 10.1007/s00784-025-06289-2. Thirty enrolled, 20 analysed, 12-week reevaluation, no significant between-group difference on any clinical parameter.
4. Tanum J, Kim HE, Lee SM, Kim A, Korostoff J, Hwang G. Photobiomodulation of Gingival Cells Challenged with Viable Oral Microbes. Journal of Dental Research. 2024;103(7):745-754. DOI 10.1177/00220345241246529. Laboratory study. The authors disclosed company co-founder interests and a United States patent application, alongside National Institutes of Health and National Science Foundation funding.
5. Al-Sharani AA, Al-Hajj WA, Madfa AA. Clinical efficacy of high versus low intensity diode laser as an adjunct to non-surgical periodontal therapy in periodontitis: randomized controlled clinical trial. Scientific Reports. 2026. DOI 10.1038/s41598-026-40879-8. Within-patient, site-level randomized trial in 27 patients across 81 quadrants and 596 sites.
6. Pakarinen S, Valimaa H, Heikkinen AM, et al. A randomized controlled trial of home-applied dual-light photodynamic therapy during supportive periodontal care (HOPE-CP study). Journal of Periodontology. 2026;97:720-731. DOI 10.1002/jper.70082. The study disclosed manufacturer funding and author financial interests in the system studied.
7. Chittabathina P, Gottumukkala SNVS, Penmetsa GS, Ramesh KSV, Mohan Kumar P, Anil Kumar K, Gokul Nishanth M. Clinical and microbiological outcomes of adjunctive photobiomodulation using various wavelengths in treatment of intrabony defects: a randomized controlled clinical trial. Lasers in Medical Science. 2025;40:471. DOI 10.1007/s10103-025-04739-7. Thirty intrabony defects, photobiomodulation added to inorganic bovine bone matrix grafting. A correction to this article was published in December 2025.

This article is for general educational purposes and is not dental advice. It does not review, rank, or recommend any device or product. Persistent bleeding, swelling, recession, periodontal pockets, tooth mobility, or other signs of periodontal disease require professional assessment. Light therapy should not be used as a substitute for diagnosis, plaque control, or indicated periodontal treatment.